We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+676.14%
AUM
$865B
AUM Growth
-$62.5B
Cap. Flow
-$15.6B
Cap. Flow %
-1.8%
Top 10 Hldgs %
34.38%
Holding
3,202
New
115
Increased
2,022
Reduced
804
Closed
71

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.82B
2
SE icon
Sea Limited
SE
+$1.38B
3
CSCO icon
Cisco
CSCO
+$1.16B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
IR icon
Ingersoll Rand
IR
+$1.03B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.54B
2
AMZN icon
Amazon
AMZN
+$1.75B
3
APH icon
Amphenol
APH
+$1.65B
4
KLAC icon
KLA
KLAC
+$1.5B
5
XEL icon
Xcel Energy
XEL
+$1.38B

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Financials 11.17%
3 Healthcare 11.1%
4 Communication Services 10.25%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABEO icon
2926
Abeona Therapeutics
ABEO
$345M
$139K ﹤0.01%
31,005
+6,878
+29% +$34.4K
IDN icon
2927
Intellicheck
IDN
$73.5M
$137K ﹤0.01%
19,500
TG icon
2928
Tredegar Corp
TG
$268M
$137K ﹤0.01%
17,211
+906
+6% +$7.57K
KULR icon
2929
KULR Technology Group
KULR
$117M
$136K ﹤0.01%
57,040
+16,462
+41% +$51.1K
LUCK
2930
Lucky Strike Entertainment
LUCK
$938M
$135K ﹤0.01%
16,149
MVIS icon
2931
Microvision
MVIS
$88.2M
$134K ﹤0.01%
208,728
-22,501
-10% -$17.2K
CVGI icon
2932
Commercial Vehicle Group
CVGI
$157M
$132K ﹤0.01%
38,483
ACDC icon
2933
ProFrac Holding
ACDC
$771M
$130K ﹤0.01%
20,888
+9,273
+80% +$49.7K
LNKB
2934
DELISTED
LINKBANCORP
LNKB
$130K ﹤0.01%
15,506
+4,083
+36% +$35.4K
AVD icon
2935
American Vanguard Corp
AVD
$73.5M
$129K ﹤0.01%
51,543
HCAT icon
2936
Health Catalyst
HCAT
$154M
$126K ﹤0.01%
99,210
+11,782
+13% +$22.2K
SENS icon
2937
Senseonics Holdings Inc
SENS
$254M
$126K ﹤0.01%
18,900
ALDX icon
2938
Aldeyra Therapeutics
ALDX
$91.7M
$125K ﹤0.01%
73,772
+9,510
+15% +$41.7K
SLP icon
2939
Simulations Plus
SLP
$371M
$125K ﹤0.01%
10,546
+354
+3% +$5.22K
CHPT icon
2940
ChargePoint
CHPT
$133M
$124K ﹤0.01%
25,478
+6,700
+36% +$40.8K
STEM icon
2941
Stem
STEM
$49.2M
$123K ﹤0.01%
13,914
+3,400
+32% +$45.7K
BALY icon
2942
Bally's
BALY
$672M
$122K ﹤0.01%
12,586
+1,853
+17% +$26.5K
OABI icon
2943
OmniAb
OABI
$294M
$122K ﹤0.01%
77,040
+23,850
+45% +$43K
ALEC icon
2944
Alector
ALEC
$164M
$121K ﹤0.01%
56,100
-103
-0.2% -$207
CHRS icon
2945
Coherus Oncology
CHRS
$217M
$121K ﹤0.01%
71,536
+11,923
+20% +$21.2K
EVCM icon
2946
EverCommerce
EVCM
$2.05B
$121K ﹤0.01%
+10,523
New +$119K
INSE icon
2947
Inspired Entertainment
INSE
$177M
$121K ﹤0.01%
16,909
+824
+5% +$6.79K
PESI icon
2948
Perma-Fix Environmental Services
PESI
$339M
$120K ﹤0.01%
11,202
WBTN
2949
WEBTOON Entertainment Inc
WBTN
$1.22B
$120K ﹤0.01%
+12,951
New +$145K
CRBP icon
2950
Corbus Pharmaceuticals
CRBP
$170M
$119K ﹤0.01%
12,572

Similar funds

T. Rowe Price Associates's Q1 2026 Portfolio in Review

As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
  • T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
  • T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
  • T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
  • T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.